Image
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft bill for Pillar 1 of its strategy. SOMAÍ Pharmaceutical‘s CEO Michael Sassano explores why the bill is a double edged sword, marking positive progress on one